Cargando…
Manganese Mineralization of Pathogenic Viruses as a Universal Vaccine Platform
Biomimetic viral mineralization improves viral vaccine stability and immunogenicity using inorganic metals such as Ca, Al, or Fe. Mn is a metal found in high concentrations in mammalian tissues; however, under natural or laboratory conditions, Mn mineralization by medical viruses has yet to be estab...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667830/ https://www.ncbi.nlm.nih.gov/pubmed/37867242 http://dx.doi.org/10.1002/advs.202303615 |
_version_ | 1785139335701463040 |
---|---|
author | Shi, Pan‐Deng Xu, Yan‐Peng Zhu, Zhu Zhou, Chao Wu, Mei He, Yangzhige Zhao, Hui Liu, Liying Zhao, Linqing Li, Xiao‐Feng Qin, Cheng‐Feng |
author_facet | Shi, Pan‐Deng Xu, Yan‐Peng Zhu, Zhu Zhou, Chao Wu, Mei He, Yangzhige Zhao, Hui Liu, Liying Zhao, Linqing Li, Xiao‐Feng Qin, Cheng‐Feng |
author_sort | Shi, Pan‐Deng |
collection | PubMed |
description | Biomimetic viral mineralization improves viral vaccine stability and immunogenicity using inorganic metals such as Ca, Al, or Fe. Mn is a metal found in high concentrations in mammalian tissues; however, under natural or laboratory conditions, Mn mineralization by medical viruses has yet to be established. Herein, a single IAV particle is successfully encapsulated with manganese phosphate (MnP) under specific conditions using the human influenza A virus (IAV). MnP‐mineralized IAVs (IAV@Mn) exhibited physiochemical and in vitro properties similar to Ca‐mineralized IAVs. In animal models, IAV@Mn shows limited replication in immune‐competent cells and a significant attenuation compared to naïve cells. Moreover, a single‐dose vaccination with IAV@Mn induced robust humoral and cellular immune responses and conferred significant protection against a wild‐type IAV challenge in mice. Thus, Mn mineralization in pathogenic viruses provides a rapid and universal strategy for generating an emergency vaccine in response to emerging viruses. |
format | Online Article Text |
id | pubmed-10667830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106678302023-10-22 Manganese Mineralization of Pathogenic Viruses as a Universal Vaccine Platform Shi, Pan‐Deng Xu, Yan‐Peng Zhu, Zhu Zhou, Chao Wu, Mei He, Yangzhige Zhao, Hui Liu, Liying Zhao, Linqing Li, Xiao‐Feng Qin, Cheng‐Feng Adv Sci (Weinh) Research Articles Biomimetic viral mineralization improves viral vaccine stability and immunogenicity using inorganic metals such as Ca, Al, or Fe. Mn is a metal found in high concentrations in mammalian tissues; however, under natural or laboratory conditions, Mn mineralization by medical viruses has yet to be established. Herein, a single IAV particle is successfully encapsulated with manganese phosphate (MnP) under specific conditions using the human influenza A virus (IAV). MnP‐mineralized IAVs (IAV@Mn) exhibited physiochemical and in vitro properties similar to Ca‐mineralized IAVs. In animal models, IAV@Mn shows limited replication in immune‐competent cells and a significant attenuation compared to naïve cells. Moreover, a single‐dose vaccination with IAV@Mn induced robust humoral and cellular immune responses and conferred significant protection against a wild‐type IAV challenge in mice. Thus, Mn mineralization in pathogenic viruses provides a rapid and universal strategy for generating an emergency vaccine in response to emerging viruses. John Wiley and Sons Inc. 2023-10-22 /pmc/articles/PMC10667830/ /pubmed/37867242 http://dx.doi.org/10.1002/advs.202303615 Text en © 2023 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Shi, Pan‐Deng Xu, Yan‐Peng Zhu, Zhu Zhou, Chao Wu, Mei He, Yangzhige Zhao, Hui Liu, Liying Zhao, Linqing Li, Xiao‐Feng Qin, Cheng‐Feng Manganese Mineralization of Pathogenic Viruses as a Universal Vaccine Platform |
title | Manganese Mineralization of Pathogenic Viruses as a Universal Vaccine Platform |
title_full | Manganese Mineralization of Pathogenic Viruses as a Universal Vaccine Platform |
title_fullStr | Manganese Mineralization of Pathogenic Viruses as a Universal Vaccine Platform |
title_full_unstemmed | Manganese Mineralization of Pathogenic Viruses as a Universal Vaccine Platform |
title_short | Manganese Mineralization of Pathogenic Viruses as a Universal Vaccine Platform |
title_sort | manganese mineralization of pathogenic viruses as a universal vaccine platform |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667830/ https://www.ncbi.nlm.nih.gov/pubmed/37867242 http://dx.doi.org/10.1002/advs.202303615 |
work_keys_str_mv | AT shipandeng manganesemineralizationofpathogenicvirusesasauniversalvaccineplatform AT xuyanpeng manganesemineralizationofpathogenicvirusesasauniversalvaccineplatform AT zhuzhu manganesemineralizationofpathogenicvirusesasauniversalvaccineplatform AT zhouchao manganesemineralizationofpathogenicvirusesasauniversalvaccineplatform AT wumei manganesemineralizationofpathogenicvirusesasauniversalvaccineplatform AT heyangzhige manganesemineralizationofpathogenicvirusesasauniversalvaccineplatform AT zhaohui manganesemineralizationofpathogenicvirusesasauniversalvaccineplatform AT liuliying manganesemineralizationofpathogenicvirusesasauniversalvaccineplatform AT zhaolinqing manganesemineralizationofpathogenicvirusesasauniversalvaccineplatform AT lixiaofeng manganesemineralizationofpathogenicvirusesasauniversalvaccineplatform AT qinchengfeng manganesemineralizationofpathogenicvirusesasauniversalvaccineplatform |